Urgency Urinary Incontinence Response Rates in Subjects With Overactive Bladder Treated With Fesoterodine 8 mg After Suboptimal Response to Tolterodine Extended Release 4 mg: A Randomized, Double-Blind, Placebo-Controlled Trial

Abstract Category

Detrusor Overactivity

Links
	Abstract 546
	Non Discussion Poster Scientific Non Discussion Poster Session 34
	Overactive Bladder Urgency Urinary Incontinence Clinical Trial Pharmacology
	1. Weill Cornell Medical College, 2. Sunnybrook Health Science Centre - University of Toronto, 3. Pfizer Inc
Abstract PDF Edit Abstract Abstract Centre